A combination of virtual reality, tactile feedback and exoskeleton training has allowed paralyzed individuals to regain both voluntary motion and sensation below the level of their spinal cord injury, scientists reported yesterday.
A combination of virtual reality, tactile feedback and exoskeleton training has allowed paralyzed individuals to regain both voluntary motion and sensation below the level of their spinal cord injury, scientists reported today.
Researchers this week reported both progress in their ability to study long-term mechanical ventilation, and in understanding how its negative consequences might be blunted.
Fiber metabolites produced by the gut microbiome improved immune defenses in several different ways. The gut microbiome ferments dietary fiber, producing short-chain fatty acids (SCFAs) along the way.
A week after Inovio Pharmaceuticals Inc. began testing its Zika vaccine, GLS-5700, in healthy volunteers, the National Institutes of Allergy and Infectious Diseases (NIAID) announced on Tuesday it has dosed the first patient in the phase I VRC 319 trial of its own Zika vaccine.
Selecta Bioscience Inc. published preclinical data this week suggesting its immune tolerance therapy SVP-Rapamycin (SEL-110), which is in a phase I trial to prevent the formation of antidrug antibodies (ADAs) to enzyme therapy for gout, could be broadly useful to prevent ADA formation to different types of biologics.
